118 related articles for article (PubMed ID: 24493285)
21. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.
Li R; Wheeler T; Dai H; Frolov A; Thompson T; Ayala G
Am J Surg Pathol; 2004 Jul; 28(7):928-34. PubMed ID: 15223964
[TBL] [Abstract][Full Text] [Related]
22. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Ross JS
Cancer; 1997 Aug; 80(4):753-63. PubMed ID: 9264360
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of NIN/RPN12 binding protein inhibits proliferation and growth in human renal cancer cells.
Jia JW; Liu AQ; Wang Y; Zhao F; Jiao LL; Tan J
Tumour Biol; 2015 Mar; 36(3):1803-10. PubMed ID: 25420906
[TBL] [Abstract][Full Text] [Related]
24. Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer.
Forootan SS; Wong YC; Dodson A; Wang X; Lin K; Smith PH; Foster CS; Ke Y
Hum Pathol; 2007 Sep; 38(9):1321-9. PubMed ID: 17599389
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
26. High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.
Nodin B; Fridberg M; Jonsson L; Bergman J; Uhlén M; Jirström K
Diagn Pathol; 2012 Jul; 7():82. PubMed ID: 22805320
[TBL] [Abstract][Full Text] [Related]
27. High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression.
Jonsson L; Gaber A; Ulmert D; Uhlén M; Bjartell A; Jirström K
Diagn Pathol; 2011 Sep; 6():91. PubMed ID: 21955582
[TBL] [Abstract][Full Text] [Related]
28. NOB1 in non-small-cell lung cancer: expression profile and clinical significance.
Liu K; Gu MM; Chen HL; You QS
Pathol Oncol Res; 2014 Apr; 20(2):461-6. PubMed ID: 24272676
[TBL] [Abstract][Full Text] [Related]
29. Expression of p120, Ki-67 and PCNA as proliferation biomarkers in imprint smears of prostate carcinoma and their prognostic value.
Bantis A; Giannopoulos A; Gonidi M; Liossi A; Aggelonidou E; Petrakakou E; Athanassiades P; Athanassiadou P
Cytopathology; 2004 Feb; 15(1):25-31. PubMed ID: 14748788
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of PDCD4 expression is an independent predictor of poor prognosis in human renal cell carcinoma patients.
Li X; Xin S; Yang D; Li X; He Z; Che X; Wang J; Chen F; Wang X; Song X
J Cancer Res Clin Oncol; 2012 Mar; 138(3):529-35. PubMed ID: 22203471
[TBL] [Abstract][Full Text] [Related]
31. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
32. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
33. Expression of MSP58 in human colorectal cancer and its correlation with prognosis.
Shi H; Li SJ; Zhang B; Liu HL; Chen CS
Med Oncol; 2012 Dec; 29(5):3136-42. PubMed ID: 22773039
[TBL] [Abstract][Full Text] [Related]
34. STEAP1 protein overexpression is an independent marker for biochemical recurrence in prostate carcinoma.
Ihlaseh-Catalano SM; Drigo SA; de Jesus CM; Domingues MA; Trindade Filho JC; de Camargo JL; Rogatto SR
Histopathology; 2013 Nov; 63(5):678-85. PubMed ID: 24025158
[TBL] [Abstract][Full Text] [Related]
35. KDM5C is overexpressed in prostate cancer and is a prognostic marker for prostate-specific antigen-relapse following radical prostatectomy.
Stein J; Majores M; Rohde M; Lim S; Schneider S; Krappe E; Ellinger J; Dietel M; Stephan C; Jung K; Perner S; Kristiansen G; Kirfel J
Am J Pathol; 2014 Sep; 184(9):2430-7. PubMed ID: 25016185
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of ZFP36 and SOCS3 expressions in human prostate cancer.
Zhu JG; Yuan DB; Chen WH; Han ZD; Liang YX; Chen G; Fu X; Liang YK; Chen GX; Sun ZL; Liu ZZ; Chen JH; Jiang FN; Zhong WD
Clin Transl Oncol; 2016 Aug; 18(8):782-91. PubMed ID: 26563146
[TBL] [Abstract][Full Text] [Related]
37. High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
Xie JJ; Zhuo YJ; Zheng Y; Mo RJ; Liu ZZ; Li BW; Cai ZD; Zhu XJ; Liang YX; He HC; Zhong WD
Int Urol Nephrol; 2017 May; 49(5):817-823. PubMed ID: 28213802
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
[TBL] [Abstract][Full Text] [Related]
39. Reduced Connexin 43 expression is associated with tumor malignant behaviors and biochemical recurrence-free survival of prostate cancer.
Xu N; Chen HJ; Chen SH; Xue XY; Chen H; Zheng QS; Wei Y; Li XD; Huang JB; Cai H; Sun XL
Oncotarget; 2016 Oct; 7(41):67476-67484. PubMed ID: 27623212
[TBL] [Abstract][Full Text] [Related]
40. TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer.
Knight JF; Shepherd CJ; Rizzo S; Brewer D; Jhavar S; Dodson AR; Cooper CS; Eeles R; Falconer A; Kovacs G; Garrett MD; Norman AR; Shipley J; Hudson DL
Br J Cancer; 2008 Dec; 99(11):1849-58. PubMed ID: 19002168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]